Current Therapeutic Research,
Journal Year:
2024,
Volume and Issue:
102, P. 100772 - 100772
Published: Dec. 31, 2024
Patients
with
metabolic
disorders
benefit
from
using
anthocyanins.
Nevertheless,
the
findings
drawn
extant
trials
remain
contentious.
Thus,
this
meta-analysis
evaluated
anthocyanin's
effect
on
inflammatory
biomarkers
in
patients
disorders.
We
comprehensively
searched
electronic
databases,
including
PubMed,
Scopus,
Web
of
Science,
and
CENTRAL,
their
inception
to
June
14,
2024.
A
total
11
randomized
controlled
clinical
14
arms
were
analyzed.
There
was
no
significant
anthocyanin
supplementation
interleukin
(IL)-1β
levels
(standardized
mean
difference
[SMD]
=
-0.01,
95%
CI:
-0.33,
0.31;
P
0.941,
I
2
62.4%,
0.031),
tumor
necrosis
factor-α
(TNF-α)
(SMD
-0.49,
-1.07,
0.09;
0.098,
94.0%,
<
0.001)
IL-6
-0.69,
-1.45,
0.06;
0.073,
95.2%,
0.001),
respectively.
between-study
heterogeneity
identified,
which
reduced
when
subgrouping
by
sample
size,
dosage,
study
population.
However,
subgroup
analysis
showed
that
it
might
decrease
TNF-α
hypertension,
if
intervention
lasted
less
than
12
weeks.
impact
IL-1β,
TNF-α,
IL-6;
however,
should
be
noted
has
a
decreasing
individuals
hypertension.
Our
observed
sizes
are
not
clinically
important.
Complementary Therapies in Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 103126 - 103126
Published: Jan. 1, 2025
Inflammatory
markers
play
a
pivotal
role
in
schizophrenia,
as
they
provide
insight
into
the
neuroinflammatory
processes
occurring
context
of
disorder.
Elevated
levels
these
markers,
particularly
C-reactive
protein
(CRP),
can
indicate
an
underlying
immune
system
dysregulation,
potentially
influencing
symptom
severity
and
progression.
Recognizing
has
led
to
investigate
use
probiotics
adjuvant
improve
treatment
schizophrenia.
The
main
objective
this
study
is
rigorously
evaluate
efficacy
reducing
plasma
CRP
patients
with
A
systematic
search
meta-analysis
were
conducted
review
randomized
clinical
trials
following
PRISMA
methodology.
strategy
((SCHIZO*
OR
PSYCHOTIC
PSYCHOSES)
AND
(PROBIOTIC*
BIFIDOBACTER*
LACTOBACILL*))
was
used
for
searching
publications
between
June-December
2024
on
PubMed,
Web
Science,
APA
PsycINFO
databases.
Individual
quality
assessed
Cochrane
risk
bias
(RoB2)
certainty
total
evidence
GRADE
system.
primary
outcome
impact
probiotic
supplementation
levels.
Out
78
studies
initially
identified,
4
finally
included
meta-analysis.
Three
out
four
found
significant
reduction
high-sensitivity
supplemented
compared
placebo
group.
pooled
analysis
revealed
supplementation,
standardized
mean
difference
(SMD)
-0.46,
(95%
CI
-0.719;
-0.201;
p
=
0.001).
synthesis
available
literature
potential
serum
schizophrenia
placebo.
However,
more
better
control
experimental
design
are
needed
before
clear
recommendation
therapy
be
made.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(1), P. 265 - 265
Published: Jan. 5, 2025
Background:
Depression
often
coexists
with
anemia,
potentially
sharing
common
pathways,
highlighting
the
need
for
treatments
addressing
both
conditions
simultaneously.
This
study
evaluated
effect
of
probiotics
on
red
blood
cell
(RBC)
parameters
in
adults
depressive
disorder.
We
hypothesized
that
would
positively
influence
RBC
parameters,
modulated
by
baseline
inflammation
or
dietary
intake,
improved
function
correlating
better
antidepressant
outcomes.
Methods:
secondary
analysis
a
two-arm,
randomized,
double-blind,
controlled
trial
involved
116
Participants
received
probiotic
formulation
containing
Lactobacillus
helveticus
Rosell®-52
and
Bifidobacterium
longum
Rosell®-175
placebo
60
days.
Data
from
97
subjects
were
analyzed
including
hemoglobin
(HGB),
count,
hematocrit
(HCT),
mean
corpuscular
volume
(MCV),
concentration
(MCH),
(MCHC),
distribution
width
(RDW).
Results:
Probiotic
supplementation
did
not
result
significant
changes
compared
to
placebo.
However,
may
help
stabilize
HGB,
HCT,
MCH,
MCHC
levels,
preventing
fluctuations
observed
group.
Conclusions:
While
showed
potential
benefits
symptoms,
observed.
Larger
studies
are
needed
clarify
mechanisms
clinical
implications.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: Feb. 26, 2025
Probiotics
supplementations
have
been
regarded
as
an
effective
strategy
for
colitis
treatment.
However,
the
effect
of
Ligilactobacillus
salivarius
Li01
on
benzo[a]pyrene
(BaP)-induced
in
Mongolian
gerbils
remains
unclear.
In
this
study,
we
leverage
a
BaP-induced
model
that
exhibits
significant
remission
following
intervention,
to
conduct
animal
experiment
integrates
histopathological
assessment,
inflammatory
cytokines,
16S
rRNA
sequencing,
targeted
metabolomic
profiling
investigate
relationship
between
Li01,
gut
microbiota,
and
colitis.
We
demonstrated
improvements
colon
assessment
cytokines
by
supplementation
are
accompanied
alterations
microbiota
structure
marked
increased
abundance
strains
with
probiotic
potential
belonging
Bifidobacterium
Eubacterium_coprostanoligenes.
Targeted
analysis
showed
increases
concentration
acetic,
propionic,
butyric,
valeric
acid.
Correlation
alteration
indicators
associated
is
closely
correlated
changed
microbial
taxa
short-chain
fatty
acids
(SCFAs).
These
data
highlighted
ameliorated
colitis,
probably
via
modulating
promoting
production
SCFAs.
Our
findings
provide
preliminary
evidence
possible
therapeutic
treatment
based
host-microbiome
interactions.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 28, 2025
Abstract
Background
Exercise-induced
inflammation,
especially
after
intense
or
prolonged
physical
activity,
can
hinder
recovery
in
athletes.
Probiotic
supplementation
has
been
suggested
as
a
potential
method
to
modulate
this
inflammatory
response
by
influencing
the
gut
microbiota.
However,
effects
of
probiotics
on
cytokine
profiles
following
exercise
remain
unclear.
This
systematic
review
and
meta-analysis
aimed
assess
impact
probiotic
modulation
athletes
aged
18–50
years
exercise.
Methods
Randomized
controlled
trials
(RCTs)
that
administered
for
at
least
one
week
were
included.
Studies
comparing
placebo
no
supplementation,
with
post-exercise
levels
primary
outcome,
analyzed.
A
search
was
conducted
across
four
databases
up
June
2024.
Risk
bias
assessed
using
McMaster
Critical
Review
Form,
random-effects
meta-analyses
performed
determine
supplementation.
Results
total
19
studies
involving
526
from
various
endurance
disciplines
included
review.
significantly
increased
anti-inflammatory
interleukin-10
(IL-10)
(SMD
=
0.43;
95%
CI:
0.25
0.61;
I²
0%).
significant
observed
other
cytokines,
including
IL-1β,
IL-6,
IL-8,
TNF-α,
IFN-γ.
Subgroup
analyses
supported
consistency
IL-10
findings
different
protocols,
though
substantial
heterogeneity
some
cytokines.
The
variability
study
designs,
strains,
dosages,
modalities
contributed
mixed
results.
Conclusion
appears
enhance
responses
post-exercise,
particularly
increasing
levels,
which
may
aid
evidence
regarding
its
pro-inflammatory
cytokines
remains
inconclusive.
Further
well-designed
RCTs
are
needed
clarify
these
establish
standardized
protocols
Abstract
Background
Abnormalities
in
glucose
and
lipid
metabolism
contribute
to
the
progression
exacerbation
of
type
2
diabetes
mellitus
(T2DM).
Fish
oil
probiotics
are
dietary
supplements
that
have
potential
improve
metabolism.
However,
their
efficacy
remains
unclear
T2DM
patients.
Methods
PubMed,
Embase,
Cochrane
Library
were
retrieved
collect
randomized
controlled
trials
(RCTs)
on
fish
or
probiotic
supplementation
patients
from
database
inception
December
13,
2023.
Primary
outcome
indicators
encompassed
glycated
hemoglobin
(HbA1c),
homeostatic
model
assessment
for
insulin
resistance
(HOMA-IR)
blood
profile
(triglyceride
(TG)
total
cholesterol
(TC).
Secondary
included
inflammatory
markers
such
as
tumor
necrosis
factor
-α
(TNF-α)
adipocytokine
(including
leptin
adiponectin).
The
R
software
was
used
statistical
analysis,
GraphPad
Prism
figure
rendering.
Results
A
60
RCTs
involving
3845
analysis.
results
showed
(
Bifidobacterium,
Lactobacillus,
Lactococcus,
Propionibacterium,
etc
.
)
more
effective
reducing
HOMA-IR
than
(Surca
=
0.935).
Bifidobacterium
demonstrated
highest
HbA1c
levels
0.963).
Regarding
metabolism,
superior
lowering
TG
TC
values
0.978
0.902,
respectively).
Furthermore,
outperformed
TNF-α
0.839)
0.712),
increasing
adiponectin
0.742).
Node-splitting
analysis
good
consistency
(P
>
0.05
direct,
indirect,
network
comparison
across
various
interventions).
Conclusions
In
patients,
regulating
Probiotics
particularly;
specifically,
higher
glucose.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Sept. 11, 2024
In
recent
years,
the
lung-gut
axis
has
received
increasing
attention.
The
oxidative
stress
and
systemic
hypoxia
occurring
in
chronic
obstructive
pulmonary
disease
(COPD)
are
related
to
gut
dysfunction.
That
suggests
probiotics
have
a
potential
therapeutic
role
COPD.
this
study,
we
therefore
evaluated
ameliorative
effects
of
on